Medical News

RSS

Number of blind persons decline in Germany

The numbers of people in Germany who are blind or visually impaired is going down. Robert P. Finger and his co-authors present their findings in the current edition of Deutsches -rzteblatt International.

21 Jul 2012

U.S. government, World Bank launch initiatives to collect more, better data on women worldwide

"The World Bank and U.S. government on Thursday each announced major new initiatives aimed at expanding knowledge on the experience of women around the world, while acknowledging that much remains to be done on filling the global 'data gap' on women," Inter Press Service reports.

21 Jul 2012

CBT, pharmacologic interventions decrease depressive symptoms in cancer patients

Despite guidelines recommending screening for depression in cancer patients, it's been unclear whether interventions designed to treat this depression are effective. A study by the University of Colorado Cancer Center and other institutions, published in the Journal of the National Cancer Institute, changes that.

21 Jul 2012

Marshall University faculty member receives $426,000 NIH grant for lung cancer study

A Marshall University faculty member has been awarded a three-year, $426,000 grant by the National Institutes of Health (NIH) to further her lung cancer research.

21 Jul 2012

Cipla, DNDi to develop ARV combination therapy for children with HIV/AIDS

On the eve of the XIX International AIDS Conference in Washington, DC, the Drugs for Neglected Diseases initiative (DNDi), a not-for-profit research and development (R&D) organization, announces a new collaboration with Indian drug manufacturer Cipla to develop and produce an improved first-line antiretroviral (ARV) combination therapy specifically adapted to meet the treatment needs of infants and toddlers living with HIV/AIDS.

21 Jul 2012

Study explores role of L. reuteri against foodborne infection

While many bacteria exist as aggressive pathogens, causing diseases ranging from tuberculosis and cholera, to plague, diphtheria and toxic shock syndrome, others play a less malevolent role and some are critical for human health.

21 Jul 2012

Viewpoints: Creating an HIV-free generation; Postal Service's struggle over retiree health benefits

HIV forces us to deal with so much: sex, drugs, poverty, racism, homelessness, homophobia, sexism, illness and death. While our nation's response has been imperfect, we have gotten a lot right. And we are now at a pivotal moment where science has led us to imagine the possibility of an HIV-free generation.

21 Jul 2012

RPB awards $110,000 grant to Mass. Eye and Ear and HMS for research into blinding diseases

Research to Prevent Blindness (RPB) has awarded a grant of $110,000 to the Massachusetts Eye and Ear Infirmary to support research into the causes, treatment and prevention of blinding diseases. The research will be directed by Joan W. Miller, M.D., Chief of the Mass. Eye and Ear and Mass. General Hospital's Departments of Ophthalmology and Chair of the Department of Ophthalmology at Harvard Medical School.

21 Jul 2012

HPV positively impacts overall survival in African Americans with oropharyngeal cancer

Even though the human papillomavirus (HPV) is a risk factor for certain head and neck cancers, its presence could make all the difference in terms of survival, especially for African Americans with throat cancer, say Henry Ford Hospital researchers.

21 Jul 2012

FDA grants accelerated approval to Onyx's Kyprolis for treatment of multiple myeloma

Onyx Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Kyprolis (carfilzomib) for Injection, a proteasome inhibitor, indicated for the treatment of patients with multiple myeloma who have received at least two prior therapies, including bortezomib and an immunomodulatory agent, and have demonstrated disease progression on or within 60 days of completion of the last therapy.

21 Jul 2012

Regeneron, Sanofi initiate enrollment in SAR236553/REGN727 Phase 3 program

Sanofi and Regeneron Pharmaceuticals, Inc. announced today that several trials within ODYSSEY, the Phase 3 clinical program of SAR236553/REGN727, have initiated patient enrollment.

21 Jul 2012

CRS: Medicaid 'maintenance-of-effort' requirement not touched by high court's Medicaid expansion decision

According to a Congressional Research Service memo, the Supreme Court's recent health law decision only touches the new Medicaid expansion provision of the health law, not penalty requirements associated with the existing program. Meanwhile, Politico Pro offers a list of states to watch as the expansion efforts continue.

21 Jul 2012

uniQure receives positive recommendation from EMA CHMP for Glybera

uniQure announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion that recommends marketing authorization of Glybera (alipogene tiparvovec) as a treatment for lipoprotein lipase deficiency (LPLD) under exceptional circumstances.

21 Jul 2012

Scientists uncover how internal mechanisms in nerve cells wire the brain

Scientists at the University of Manchester have uncovered how the internal mechanisms in nerve cells wire the brain. The findings open up new avenues in the investigation of neurodegenerative diseases by analysing the cellular processes underlying these conditions.

21 Jul 2012

Onyx receives FDA approval for Kyprolis to treat multiple myeloma

The Multiple Myeloma Research Foundation (MMRF) today announced that its partner, Onyx Pharmaceuticals, Inc., received U.S. Food and Drug Administration (FDA) approval for Kyprolis (carfilzomib) for the treatment of patients with multiple myeloma who have received at least two prior therapies, including Velcade (bortezomib) for Injection and an immunomodulatory agent, such as Thalomid (thalidomide) or Revlimid (lenalidomide), and have demonstrated disease progression on or within 60 days of completion of the last therapy.

21 Jul 2012

Vitamin D might modify damaging effects of smoking on lung function

Vitamin D deficiency is associated with worse lung function and more rapid decline in lung function over time in smokers, suggesting that vitamin D may have a protective effect against the effects of smoking on lung function, according to a new study from researchers in Boston.

21 Jul 2012

Views on health reform: U.S. not getting value for its spending; Cutting doctors' school debt to curb costs

When it comes to healthcare, Americans are not getting a lot of value for their money. The United States spends 17.6% of its gross domestic product, nearly twice the average of the nations in the Organization for Economic Cooperation and Development. But life expectancy in the United States in 2010, at 78.7 years, is below the OECD average of 79.8 years. The U.S. infant mortality rate is higher than in most developed countries - it is higher than the rates in Greece, Hungary and Slovakia.

21 Jul 2012

Caregivers of stroke survivors are at risk for depression and complications from chronic stress

Caregivers of stroke survivors are at risk for developing depression and complications from chronic stress, according to a study published by researchers at the Loyola University Chicago Marcella Niehoff School of Nursing (MNSON) in the latest issue of Biological Research for Nursing.

21 Jul 2012

Study identifies genetic markers that influence sex hormone-binding globulin

A research study led by Boston University School of Medicine (BUSM) and the University of Exeter in the United Kingdom, in collaboration with a global consortium, has identified genetic markers that influence a protein involved in regulating estrogen and testosterone levels in the bloodstream.

21 Jul 2012

Novartis receives FDA approval for Afinitor to treat HER2-negative breast cancer

The U.S. Food and Drug Administration today approved Afinitor (everolimus) for use in combination with Aromasin (exemestane) to treat certain postmenopausal women with advanced hormone-receptor positive, HER2-negative breast cancer.

21 Jul 2012

Medical News

Number of blind persons decline in Germany

U.S. government, World Bank launch initiatives to collect more, better data on women worldwide

CBT, pharmacologic interventions decrease depressive symptoms in cancer patients

Marshall University faculty member receives $426,000 NIH grant for lung cancer study

Cipla, DNDi to develop ARV combination therapy for children with HIV/AIDS

Study explores role of L. reuteri against foodborne infection

Viewpoints: Creating an HIV-free generation; Postal Service's struggle over retiree health benefits

RPB awards $110,000 grant to Mass. Eye and Ear and HMS for research into blinding diseases

HPV positively impacts overall survival in African Americans with oropharyngeal cancer

FDA grants accelerated approval to Onyx's Kyprolis for treatment of multiple myeloma

Regeneron, Sanofi initiate enrollment in SAR236553/REGN727 Phase 3 program

CRS: Medicaid 'maintenance-of-effort' requirement not touched by high court's Medicaid expansion decision

uniQure receives positive recommendation from EMA CHMP for Glybera

Scientists uncover how internal mechanisms in nerve cells wire the brain

Onyx receives FDA approval for Kyprolis to treat multiple myeloma

Vitamin D might modify damaging effects of smoking on lung function

Views on health reform: U.S. not getting value for its spending; Cutting doctors' school debt to curb costs

Caregivers of stroke survivors are at risk for depression and complications from chronic stress

Study identifies genetic markers that influence sex hormone-binding globulin

Novartis receives FDA approval for Afinitor to treat HER2-negative breast cancer

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News